Omada Health (OMDA) vs ORIC Pharmaceuticals, Inc. (ORIC)
A side-by-side comparison of Omada Health and ORIC Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
OMDA
Omada Health
$20.61HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
ORIC
ORIC Pharmaceuticals, Inc.
$12.01HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
Total return — OMDA vs ORIC
growth of $100 · dividends reinvested · last 1yOMDA -8.9% (-8.9%/yr)ORIC +34.0% (+34.0%/yr)ORIC compounded faster over this window
OMDA ORIC
OMDA vs ORIC: by the numbers
- •ORIC is the larger company ($1.24B vs $1.23B market cap).
- •OMDA is profitable (1.39% net margin) while ORIC runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | OMDA | ORIC |
|---|---|---|
| P/E ratio | 327.19 | N/A |
| P/S ratio | 3.96 | N/A |
| P/B ratio | 4.85 | 3.26 |
| EV / EBITDA | 144.65 | N/A |
| FCF yield | 1.64% | N/A |
Profitability
| Metric | OMDA | ORIC |
|---|---|---|
| Gross margin | 68.19% | 0.00% |
| Operating margin | -0.15% | 0.00% |
| Net margin | 1.39% | 0.00% |
| ROE | 1.70% | -36.81% |
| ROIC | -0.18% | -40.32% |
Growth (annualized)
| Metric | OMDA | ORIC |
|---|---|---|
| Total return CAGR (5Y) | N/A | -8.73% |
Frequently asked
- Is OMDA or ORIC more profitable?
- OMDA runs the higher net margin — OMDA at 1.39% versus ORIC at 0.00%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.